WIA
CLVS

Wealthstreet Investment Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Wealthstreet Investment Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-19,800
Closed -$294K – 347
2019
Q2 		$294K Sell
19,800
-9,750
-33% -$176K 0.04% 282
2019
Q1 		$733K Hold
29,550
– – 0.1% 175
2018
Q4 		$730K Sell
29,550
-2,350
-7% -$48K 0.1% 169
2018
Q3 		$937K Sell
31,900
-13,130
-29% -$508K 0.12% 161
2018
Q2 		$2.05M Sell
45,030
-3,700
-8% -$180K 0.27% 92
2018
Q1 		$2.57M Buy
48,730
+1,750
+4% +$102K 0.32% 76
2017
Q4 		$3.19M Buy
+46,980
New +$3.28M 0.39% 66

Other funds holding CLVS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return